Patient trajectories after diagnosis of diffuse large B-cell lymphoma—a multistate modelling approach to estimate the chance of lasting remission

BACKGROUND: Achieving lasting remission for at least 2 years is a good indicator for favourable prognosis long term after Diffuse large B-cell lymphoma (DLBCL). The aim of this study was to provide real-world probabilities, useful in risk communication and clinical decision-making, of the chance for...

Descripción completa

Detalles Bibliográficos
Autores principales: Ekberg, Sara, Crowther, Michael, Harrysson, Sara, Jerkeman, Mats, E. Smedby, Karin, Eloranta, Sandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596493/
https://www.ncbi.nlm.nih.gov/pubmed/35999271
http://dx.doi.org/10.1038/s41416-022-01931-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596493/
https://www.ncbi.nlm.nih.gov/pubmed/35999271
http://dx.doi.org/10.1038/s41416-022-01931-2

Ejemplares similares